DS

Daniel Sharp

Botanix Pharmaceuticals Ltd | Non-Executive Director
Mr Sharp is an investment banker with more than 30 years of experience in capital markets globally, advising the boards of technology and healthcare-based organisations. He also has experience in sourcing and servicing both of institutional and private wealth investors globally. Mr Sharp was a Corporate Finance Executive Director of Canaccord Genuity for 8 years and previously spearheaded the Corporate Finance departments at both Shaw and Partners and Lodge Partners.

Companies and Roles

Company
Title
Tenure
Since
BOT
Botanix Pharmaceuticals Ltd
  • Non-Executive Director
3yrsMar 2022
ALC
Alcidion Group Limited
  • Non-Executive Director
3yrs, 6mthSep 2021

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
BOT
Botanix Pharmaceuticals Ltd
30/06/24N/A2,131,3134,000,000N/A
ALC
Alcidion Group Limited
30/06/241,378,572N/AN/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
BOT
Botanix Pharmaceuticals Ltd
02/12/24
Issued
3,000,000$0.350$1,050,000Issue of securities
ALC
Alcidion Group Limited
26/04/24
Transfer
800,000$0.055$44,000Off-market transfer
ALC
Alcidion Group Limited
26/04/24
Buy
250,000$0.052$13,070On-market trade
ALC
Alcidion Group Limited
26/04/24
Transfer
800,000$0.055$44,000Off-market transfer
ALC
Alcidion Group Limited
09/05/23
Buy
210,000$0.096$20,230On-market trade